Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 80 M76 M79 M80 M78 M70 M 307 M Research & development —————— — Operating income 521 M728 M748 M804 M761 M782 M 3.1 B Non-Operating Income, Total -91 M0001 M-1 M 0 Interest expense, net of interest capitalized 437 M383 M403 M403 M375 M337 M 1.52 B Non-Operating Income, excl. Interest Expenses -528 M-383 M-403 M-403 M-374 M-338 M -1.52 B Unusual income/expense —————— — Pretax income 210 M285 M309 M344 M342 M342 M 1.34 B Equity in earnings —————— — Taxes 40 M63 M64 M78 M77 M76 M 295 M Non-controlling/minority interest 4 M4 M4 M4 M4 M4 M 16 M After tax other income/expense —————— — Net income before discontinued operations 166 M218 M241 M262 M261 M262 M 1.03 B Discontinued operations —————— — Net income 166 M218 M241 M262 M261 M262 M 1.03 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 157 M213 M233 M254 M256 M257 M 1 B Basic earnings per share (Basic EPS) 0.30.410.460.50.520.54 2.02 Diluted earnings per share (Diluted EPS) 0.290.410.450.50.510.53 1.99 Average basic shares outstanding 540.32 M517.12 M508.13 M504.86 M505.13 M480.31 M — Diluted shares outstanding 544.28 M523.42 M513.61 M510.35 M511.11 M486.87 M — EBITDA 699 M733 M744 M782 M758 M789 M 3.07 B EBIT 497 M712 M724 M776 M741 M767 M 3.01 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 24 M21 M20 M6 M17 M22 M 65 M